Good to know even if you're not very high risk and do some Daty at a MP. I bet sales are going to hit the sky.
CDC recommendation relies on findings of earlier studies assessing efficacy of antibiotic doxycycline against STDs
The Centers for Disease Control and Prevention (CDC) proposed a new guideline this week for high-risk patients to take the antibiotic known as doxycycline as a morning-after pill to decrease the risk of sexually transmitted infections (STIs).
Experts say health officials will likely endorse the guideline, which was published on Monday in the Federal Register.
The public has 45 days to comment on the proposal.
The CDC's guideline is based on previous studies that show a "demonstrated benefit" in specifically reducing chlamydia, gonorrhea, and syphilis infections after people took a single 200 milligram doxycycline pill no later than 72 hours after unprotected sex.
The CDC originally concluded in its previous 2021 sexually transmitted infection treatment guidelines that more research was needed regarding whether doxycycline was effective at preventing sexually transmitted infections.
Gay, bisexual men and transgender women
Several recent randomized trials, however, showed that when high-risk patients took doxycycline within three days of unprotected sex, they were significantly less likely to get chlamydia, syphilis or gonorrhea — compared with people who did not take the pills after sex.
The studies focused on gay and bisexual men as well as transgender women at higher risk to contract a sexually transmitted infection.
One of the most prominent of these recent studies was published in The New England Journal of Medicine earlier this year.
It showed a two-thirds decrease in the incidence of syphilis, gonorrhea and chlamydia among study participants, all of whom had a sexually transmitted infection within the previous year.
www.foxnews.com
CDC recommendation relies on findings of earlier studies assessing efficacy of antibiotic doxycycline against STDs
The Centers for Disease Control and Prevention (CDC) proposed a new guideline this week for high-risk patients to take the antibiotic known as doxycycline as a morning-after pill to decrease the risk of sexually transmitted infections (STIs).
Experts say health officials will likely endorse the guideline, which was published on Monday in the Federal Register.
The public has 45 days to comment on the proposal.
The CDC's guideline is based on previous studies that show a "demonstrated benefit" in specifically reducing chlamydia, gonorrhea, and syphilis infections after people took a single 200 milligram doxycycline pill no later than 72 hours after unprotected sex.
The CDC originally concluded in its previous 2021 sexually transmitted infection treatment guidelines that more research was needed regarding whether doxycycline was effective at preventing sexually transmitted infections.
Gay, bisexual men and transgender women
Several recent randomized trials, however, showed that when high-risk patients took doxycycline within three days of unprotected sex, they were significantly less likely to get chlamydia, syphilis or gonorrhea — compared with people who did not take the pills after sex.
The studies focused on gay and bisexual men as well as transgender women at higher risk to contract a sexually transmitted infection.
One of the most prominent of these recent studies was published in The New England Journal of Medicine earlier this year.
It showed a two-thirds decrease in the incidence of syphilis, gonorrhea and chlamydia among study participants, all of whom had a sexually transmitted infection within the previous year.
Antibiotic doxycycline can be morning-after pill for high-risk patients after unprotected sex, CDC suggests
CDC officials are set to endorse the use of a common antibiotic as a morning-after preventive measure for gay and bisexual men to combat increasingly prevalent sexually transmitted infections.
www.foxnews.com
